痰热清注射液治疗肺结核并发下呼吸道感染

Clinical Observation of the Treatment of Pulmonary Tuberculosis with Lower Respiratory Infection with Tanreqing Injection

目的:观察痰热清注射液治疗肺结核并发下呼吸道感染的临床疗效。方法:患者64例,随机分为痰热清治疗组和头孢呋辛钠对照组,观察在抗结核治疗基础上,痰热清注射液治疗肺结核并发下呼吸道感染的临床疗效。结果:痰热清治疗组有效率93．8％,对照组有效率96．9％,两组治疗比较差异无统计学意义,但治疗组热程明显缩短。结论:痰热清治疗肺结核并发下呼吸道感染有良好的临床疗效,不良反应轻,值得临床应用。

Objective： To observe the clinical therapeutic effect of tanreqing injection in the treatment of pulmonary tuberculosis accompanied with lower respiratory infection. Method： 64 patients with lung tuberculosis with lower respiratory infections were randomly divided into tanreqing therapy group and Cefuroxime sodium control group. The clinical therapeutic effects of tanreqing on pulmonary tuberculosis with lower respiratory infections were observed on the basis of antituberculosis treatment. Result. The effective rates were 93.8% and 96.9% in the tanreqing therapy group and the control group, respectively. The differences were not statistically significant between the two groups, but the fever period was obviously shorter in the therapy group. Conclusion： The clinical therapeutic effects of tanreqing are satisfactory in the treatment of pulmonary tuberculosis with lower respiratory infections with light adverse reactions and therefore, it deserves its clinical application.